Bateman, L., Rao, P., Jones, T. H., & Kelly, D. M. (2020). SAT-049 Testosterone Therapy Reduces Inflammatory Activation of Human Monocytes in Hypogonadal Type-2 Diabetic Men as a Potential Mechanism to Improve Atherosclerosis. J Endocr Soc.
Citación estilo ChicagoBateman, Lauren, Preethi Rao, Thomas Hugh Jones, and Daniel Marcus Kelly. "SAT-049 Testosterone Therapy Reduces Inflammatory Activation of Human Monocytes in Hypogonadal Type-2 Diabetic Men As a Potential Mechanism to Improve Atherosclerosis." J Endocr Soc 2020.
Cita MLABateman, Lauren, Preethi Rao, Thomas Hugh Jones, and Daniel Marcus Kelly. "SAT-049 Testosterone Therapy Reduces Inflammatory Activation of Human Monocytes in Hypogonadal Type-2 Diabetic Men As a Potential Mechanism to Improve Atherosclerosis." J Endocr Soc 2020.